title: Venous and arterial thrombosis following administration of intravenous immunoglobulins: reply to Feuillet and colleagues.
authors.forename: Ronen
authors.initials: R
authors.lastname: Ben-Ami
authors.forename: Daphna
authors.initials: D
authors.lastname: Paran
authors.forename: Yair
authors.initials: Y
authors.lastname: Herishanu
authors.forename: Ori
authors.initials: O
authors.lastname: Elkayam
authors.forename: Ludmila
authors.initials: L
authors.lastname: Shopin
mesh_terms: D000283:Administration, Intravesical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous